Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

Cytokeratin 5 anticorps

KRT5 Reactivité: Humain WB, IHC, ELISA Hôte: Souris Monoclonal 3E2F1 unconjugated
N° du produit ABIN969078
  • Antigène Voir toutes Cytokeratin 5 (KRT5) Anticorps
    Cytokeratin 5 (KRT5) (Keratin 5 (KRT5))
    Reactivité
    • 119
    • 76
    • 49
    • 12
    • 10
    • 10
    • 3
    • 3
    • 3
    • 3
    • 3
    • 3
    • 3
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    Humain
    Hôte
    • 85
    • 44
    • 1
    Souris
    Clonalité
    • 72
    • 58
    Monoclonal
    Conjugué
    • 63
    • 15
    • 10
    • 4
    • 4
    • 4
    • 4
    • 4
    • 4
    • 3
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    Cet anticorp Cytokeratin 5 est non-conjugé
    Application
    • 90
    • 50
    • 46
    • 32
    • 25
    • 22
    • 16
    • 14
    • 13
    • 8
    • 7
    • 6
    • 5
    • 5
    • 2
    • 2
    • 1
    Western Blotting (WB), Immunohistochemistry (IHC), ELISA
    Purification
    purified
    Immunogène
    Purified recombinant fragment of CK5 expressed in E. coli.
    Clone
    3E2F1
    Isotype
    IgG1
    Top Product
    Discover our top product KRT5 Anticorps primaire
  • Indications d'application
    ELISA: 1:10000, WB: 1:500 - 1:2000, IHC: 1:200 - 1:1000
    Restrictions
    For Research Use only
  • Format
    Liquid
    Buffer
    Ascitic fluid containing 0.03 % sodium azide.
    Agent conservateur
    Sodium azide
    Précaution d'utilisation
    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Stock
    4 °C/-20 °C
    Stockage commentaire
    4°C, -20°C for long term storage
  • Canedo-Patzi, León-Bojorge, de Ortíz-Hidalgo: "[Adenomatoid tumor of the genital tract. Clinical, pathological and immunohistochemical study in 9 cases]." dans: Gaceta médica de México, Vol. 142, Issue 1, pp. 59-66, (2006) (PubMed).

    Leibl, Moinfar: "Mammary NOS-type sarcoma with CD10 expression: a rare entity with features of myoepithelial differentiation." dans: The American journal of surgical pathology, Vol. 30, Issue 4, pp. 450-6, (2006) (PubMed).

  • Antigène
    Cytokeratin 5 (KRT5) (Keratin 5 (KRT5))
    Autre désignation
    Cytokeratin 5 (KRT5 Produits)
    Synonymes
    anticorps 3300001P10Rik, anticorps AW146334, anticorps CK5, anticorps K5, anticorps Krt2-5, anticorps Tfip8, anticorps DDD, anticorps DDD1, anticorps EBS2, anticorps KRT5A, anticorps Sak57, anticorps ckii, anticorps wu:fb02h09, anticorps wu:fj02d02, anticorps wu:fk78b12, anticorps zfCKII, anticorps KRT75, anticorps CK-5, anticorps Keratin-5, anticorps keratin 5, anticorps Krt5, anticorps KRT5, anticorps krt5
    Sujet

    Description: CK5 (keratin 5) is a member of the keratin gene family. Biochemically, most members of the CK family fall into one of two classes, type I (acidic polypeptides) and type II (basic polypeptides). The type II cytokeratins consist of basic or neutral proteins which are arranged in pairs of heterotypic keratin chains coexpressed during differentiation of simple and stratified epithelial tissues. This type II cytokeratin is specifically expressed in the basal layer of the epidermis with family member KRT14. The type II cytokeratins are clustered in a region of chromosome 12q12-q13. At least one member of the acidic family and one member of the basic family is expressed in all epithelial cells. Cytokeratin 5 is expressed in normal basal cells. Mutations of the Cytokeratin5 gene (KRT5) have been shown to result in the autosomal dominant disorderepidermolysis bullosa (EB). Defects in KRT5 are a cause of epidermolysis bullosa simplex.

    Aliases: K5, DDD, EBS2, KRT5A, KRT5

    ID gène
    3852
    HGNC
    3852
Vous êtes ici:
Support technique